Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Restocking of Isoflurane to commence from February
Zoetis supplies around two-thirds of the UK’s isoflurane anaesthetic gas.

Zoetis issues update on IsoFlo supply

Restocking of the supply chain of IsoFlo - the leading brand of Isoflurane in the UK - is scheduled to commence from February, manufacturer Zoetis has confirmed.

In a press release, the animal health firm said: ‘Close communication and partnership will be maintained with wholesalers, the VMD, BVA, BSAVA, BEVA, and industry stakeholders alongside our veterinary customers to ensure the smoothest transition back to restocking and meeting the industries demand for IsoFlo.

‘Starting from February we will be managing a series of deliveries of IsoFlo back into the UK supply chain until will are able to meet the full demand. This may take several months to complete.’

Zoetis supplies around two-thirds of the UK’s isoflurane anaesthetic gas. But in December, it was announced that their third-party manufacturer had to cease production due to a mechanical issue on the production line.

The supply problem raised concerns by some vets they would not be able to perform emergency surgery over the Christmas period, and that they may be disciplined by the RCVS for clinical decisions that may arise from the shortage.

In response, the RCVS published a statement to reassure the profession that any problems that might arise from the shortage are unlikely to be considered a professional conduct issue. The shortage also prompted the BSAVA to commission a webinar discussing alternative solutions.

 

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'